Intellia Therapeutics Inc... (NTLA)
NASDAQ: NTLA
· Real-Time Price · USD
10.99
0.09 (0.83%)
At close: Aug 15, 2025, 3:59 PM
11.03
0.36%
After-hours: Aug 15, 2025, 05:44 PM EDT
Intellia Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 52.86M | 45.57M | 57.88M | 43.09M | 45.97M | 52.6M | 36.27M | 51.77M | 53.04M | 53.48M | 52.12M | 51.4M | 45.34M | 37.86M | 33.05M | 26.79M | 41.81M | 51.52M |
Cost of Revenue | 5.17M | 7.77M | 10.29M | 10.19M | 9.87M | 9.44M | 8.98M | 8.54M | 102.9M | 102.57M | 102.27M | 102.12M | 65.96M | 123M | 160.53M | 196.88M | 176.15M | 155.03M |
Gross Profit | 47.68M | 37.8M | 47.59M | 35.51M | 36.1M | 43.17M | 27.3M | 43.22M | -49.86M | -49.09M | -50.15M | -50.72M | -20.62M | -85.14M | -127.47M | -170.08M | -134.34M | -103.51M |
Operating Income | -512.02M | -541.07M | -534.26M | -537.71M | -524.04M | -517.34M | -515.29M | -485.49M | -459.91M | -425.88M | -458.16M | -428.49M | -394.95M | -365.67M | -267.85M | -229.83M | -185.94M | -149.96M |
Interest Income | 38.76M | 43.78M | 47.81M | 49.63M | 50.25M | 50.48M | 49.83M | 42.73M | 31.93M | 19.98M | 8.54M | 3.69M | 2.1M | 1.6M | 1.28M | 987K | 900K | 1.33M |
Pretax Income | -480.19M | -525.91M | -519.02M | -522.28M | -508.8M | -485.5M | -481.19M | -462.44M | -453.44M | -430.44M | -474.19M | -442.02M | -400.43M | -368.56M | -267.89M | -228.85M | -185.04M | -148.63M |
Net Income | -480.19M | -525.91M | -519.02M | -522.28M | -508.8M | -485.5M | -470.41M | -454.98M | -445.98M | -422.27M | -476.8M | -441.31M | -399.73M | -368.56M | -267.89M | -228.85M | -185.04M | -148.63M |
Selling & General & Admin | 119.16M | 123.75M | 125.83M | 122.38M | 121.28M | 120.14M | 116.5M | 111.13M | 103.87M | 95.35M | 90.31M | 88.79M | 85.35M | 79.91M | 71.1M | 59.75M | 51.61M | 46.45M |
Research & Development | 443.15M | 457.73M | 458.63M | 453.3M | 443.62M | 447.29M | 435.07M | 426.12M | 409.08M | 384M | 419.98M | 391.11M | 354.94M | 323.63M | 229.81M | 196.88M | 176.15M | 155.03M |
Other Expenses | n/a | n/a | n/a | -2.47M | -4.76M | -4.76M | -4.76M | -2.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 562.31M | 581.47M | 584.46M | 573.22M | 560.14M | 562.67M | 546.81M | 534.96M | 512.95M | 479.35M | 510.29M | 479.89M | 440.3M | 403.53M | 300.9M | 256.63M | 227.75M | 201.48M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 564.88M | 586.64M | 592.14M | 580.79M | 570.01M | 569.94M | 551.57M | 537.25M | 512.95M | 479.35M | 510.29M | 479.89M | 440.3M | 403.53M | 300.9M | 256.63M | 227.75M | 201.48M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -10.78M | -7.46M | -7.46M | -8.16M | 2.5M | -822K | -822K | -119K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 103.73M | 103.5M | 101.86M | 101M | 96.97M | 95.5M | 90.46M | 88.64M | 88.19M | 87.77M | 81.22M | 76.05M | 75.7M | 74.75M | 74.43M | 73.71M | 68.16M | 67.18M |
Shares Outstanding (Diluted) | 103.73M | 103.5M | 101.86M | 101M | 96.97M | 95.5M | 90.46M | 88.64M | 88.19M | 87.77M | 81.22M | 76.05M | 75.82M | 74.75M | 74.43M | 73.71M | 68.16M | 67.18M |
EPS (Basic) | -4.69 | -5.23 | -5.25 | -5.44 | -5.48 | -5.36 | -5.29 | -5.27 | -5.38 | -5.3 | -6.21 | -5.86 | -5.34 | -5.03 | -3.76 | -3.36 | -2.86 | -2.46 |
EPS (Diluted) | -4.69 | -5.23 | -5.25 | -5.44 | -5.48 | -5.36 | -5.29 | -5.27 | -5.38 | -5.3 | -6.21 | -5.86 | -5.34 | -5.03 | -3.76 | -3.36 | -2.86 | -2.46 |
EBITDA | -501.87M | -530.8M | -523.98M | -527.52M | -514.18M | -507.9M | -506.31M | -476.94M | -451.71M | -418.01M | -450.59M | -421.07M | -387.7M | -358.62M | -260.96M | -223.22M | -179.51M | -143.6M |
EBIT | -512.02M | -541.07M | -534.26M | -537.71M | -524.04M | -517.34M | -515.29M | -485.49M | -459.91M | -425.88M | -458.16M | -428.49M | -394.95M | -365.67M | -267.85M | -229.83M | -185.94M | -149.96M |
Depreciation & Amortization | 10.15M | 10.27M | 10.29M | 10.19M | 9.87M | 9.44M | 8.98M | 8.54M | 8.2M | 7.87M | 7.57M | 7.42M | 7.26M | 7.05M | 6.89M | 6.61M | 6.43M | 6.36M |